Platelet growth factors: potential impact on transfusion medicine
- PMID: 10204598
- DOI: 10.1046/j.1537-2995.1999.39399219292.x
Platelet growth factors: potential impact on transfusion medicine
Similar articles
-
Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?Leukemia. 1999 Apr;13 Suppl 1:S14-8. Leukemia. 1999. PMID: 10232362 Review.
-
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.Exp Hematol. 2002 Sep;30(9):1044-50. doi: 10.1016/s0301-472x(02)00878-0. Exp Hematol. 2002. PMID: 12225796 Clinical Trial.
-
The impact of thrombopoietin and related Mpl-ligands on transfusion medicine.Transfus Med Rev. 1997 Oct;11(4):243-55. Transfus Med Rev. 1997. PMID: 9345706 Review. No abstract available.
-
Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.J Hematother. 1996 Aug;5(4):407-14. doi: 10.1089/scd.1.1996.5.407. J Hematother. 1996. PMID: 8877716 Review.
-
Use of thrombopoietic growth factors in acute leukemia.Leukemia. 2000 Mar;14(3):505-8. doi: 10.1038/sj.leu.2401620. Leukemia. 2000. PMID: 10720151 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources